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ABSTRACT
OBJECTIVE: To evaluate optical rhinometry (ORM) as an ob-
jective evaluation of nasal patency using nasal provocation testing
with Dermatophagoides farinae (Df ) as compared with acoustic
rhinometry.
STUDY DESIGN: Prospective pilot.
SETTING: Academic rhinologic practice.
SUBJECTS AND METHODS: Five adult healthy controls and
five adult subjects with allergic rhinitis (AR) underwent nasal
provocation testing with increasing concentrations of Df while
undergoing ORM. The minimum concentration of Df causing a
positive reading was recorded. Nasal cross-sectional area was
measured before and after testing using acoustic rhinometry. Nasal
patency was assessed subjectively after each challenge with the
visual analogue scale.
RESULTS: The median amount of Df causing a positive re-
sponse on ORM was less in AR patients as compared to healthy
controls, at 5000 AU/mL and greater than 10,000 AU/mL, respec-
tively. There was a statistically significant correlation between the
change in optical density in ORM and subjective nasal congestion
after increasing Df challenges (r  0.63; P  0.0007). Similarly,
there was a statistically significant correlation between change in
optical density by ORM and both minimum cross-sectional areas as
measured by acoustic rhinometry (r  0.60, P  0.03; and r 
0.64, P  0.02, respectively).
CONCLUSION: This is the first study to show a correlation
between optical rhinometry and acoustic rhinometry during nasal
provocation testing with Df. In addition, the data support a corre-
lation of optical rhinometry to subjective symptoms of nasal con-
gestion. These preliminary data suggest that optical rhinometry is
able to assess changes in nasal patency during challenges with Df.
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doi:10.1016/j.otohns.2010.02.034Allergic rhinitis (AR) is an IgE-mediated response toinhaled antigens in the nose causing the release of imme-
diate and delayed mediators, which then lead to mucosal gland
stimulation and increased vascular permeability. Patients com-
plain of symptoms such as nasal obstruction, rhinorrhea, sneez-
ing, and watery eyes; symptoms can last hours to days.
In the United States, patients who are suspected by his-
tory and physical examination to have AR may undergo
objective testing by way of either skin or in vitro blood
testing (modified radioallergosorbent test). Skin testing has
been questioned regarding its accuracy in detecting inhalant
allergies. Sensitivity and specificity of epicutaneous testing in
predicting nasal response to Alternaria was 42 percent and 44
percent, with only a modest increase to 58 percent when
followed by the addition of intradermal testing. Other antigens
such as timothy grass are better, with 87 percent sensitivity and
86 percent specificity.1,2 Currently, there is no “gold standard”
objective testing method for inhalant allergies.3
Recently, nasal provocation testing (NPT) has been used
in the attempt to characterize the response to an allergen
challenge. The antigen is introduced into the nasal cavity
and nasal mucosal swelling is monitored. NPT is used
widely throughout Europe as a clinical tool to evaluate
inhalant allergies; however, it has been limited to research
purposes in the United States.
The most common objective methods to monitor nasal
patency are rhinomanometry and acoustic rhinometry
(AcR). Both rhinomanometry and AcR have been validated
and are standardized for clinical use in Europe, but are
mainly used in scientific research in the United States.
Optical rhinometry (ORM) is a new technique intro-
duced in Germany in 2004 under the trademark Rhinolux
(Rhios GmbH, Groerkmannsdorf, Germany).4 The device
works via optical spectroscopy, which measures the absorp-
tion of visible and near-infrared light in tissue. In the same
way that pulse oximetry measures hemoglobin absorption of
near-infrared light and thus oxygen blood saturation, the4, 2010.
k Surgery Foundation. All rights reserved.
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cavity. An emitter and detector are placed at the nasal
dorsum and swelling is measured as the extinction of light,
or optical density (OD), as a function of time. Nasal prov-
ocation studies using histamine and allergens have shown
correlation with subjective findings and objective measure-
ments with anterior rhinomanometry.4-7 Threshold for the
detection of a significant positive response to antigens was
determined to be 0.2 OD.4 Advantages of ORM include
improved patient comfort, technical ease of use, ability to
obtain real-time data, and ability to obtain measurements in
patients with nasal polyposis, choanal atresia, and septal
perforations in patients who cannot undergo testing with the
acoustic rhinometer or rhinomanometry. Previous work by
Luong et al found a strong correlation between ORM and
subjective symptoms on nasal congestion in both healthy con-
trols and allergic subjects when challenged with histamine.8
The purpose of this study is to compare ORM as an objec-
tive evaluation of nasal patency using NPT with Dermato-
phagoides farinae (Df) and to compare ORM with AcR.
Materials and Methods
Patients
Eleven subjects (7 male and 4 female), six with AR and five
healthy controls (HCs), were enrolled in this study after
Institutional Review Board approval from the University of
Texas Health Science Center at Houston. Participants were
aged 22 to 54 years. The median age was 29. One AR
subject was excluded from the study after his flat nasal
bridge made measurement with ORM not possible. The
HCs had no history of allergy symptoms such as sneezing,
rhinorrhea, and/or itchy eyes and no history of using anti-
histamines or nasal steroid sprays. AR subjects had symp-
toms of allergic rhinitis consisting of sneezing, rhinorrhea,
and/or itchy eyes and skin test positive for Df.
The following patients were excluded from the study:
pregnant patients; those with asthma or lung disease, a history
of immunotherapy or immunodeficiency, chronic rhinosinus-
itis, sinonasal polyps, or history of sinus surgery within eight
weeks; patients taking beta-blockers; patients with dermatog-
raphism, latex sensitivity, or previous systemic reaction to skin
testing; and patients who had an episode of rhinitis in the past
month or who were currently symptomatic.
Patients were asked to discontinue the following medi-
cations: antihistamines were discontinued three days prior;
topical, nasal, and systemic corticosteroids one week prior,
tricyclic antidepressants one week prior, and H2 blockers
and leukotriene receptor antagonists one day prior.
Study Design
Each subject underwent NPT with three increasing concentra-
tions (1000 AU/mL, 5000 AU/mL, and 10,000 AU/mL) of Df
antigen (Hollister-Stier Laboratories, Uttar Pradesh, India).
The subjects were monitored by ORM during the entire course
of the NPT. Prior to the first challenge, measurements with theacoustic rhinometer (AcR) were taken of each nasal cavity and
a baseline visual analogue scale (VAS) rating for subjective
nasal congestion was recorded. Starting with a 1000 AU/mL
Df challenge to the right nasal cavity, continuous measure-
ments with the optical rhinometer were obtained for at least 10
minutes at each dose of Df. If a change in OD of less than 0.2
was noted by ORM, then the next-higher Df dose was admin-
istered until there was at least a 0.2 change in OD or the
maximum 10,000 AU/mL was given. The value of 0.2 OD is
the published value of a positive response for the optical
rhinometer.4 Measurement with optical rhinometer was con-
tinued for 20 minutes at this final Df amount. After this 20-
minute recording, measurements from the AcR from each
nasal cavity were taken. VAS assessments were obtained from
the subject after each Df challenge.
Nasal Provocation Testing
Each subject was first fitted with the spectacles-like frame
of the optical rhinometer. Then, five measurements from
each nostril were taken with the AcR. The average value
from these five measurements was reported. A two-minute
baseline ORM recording was performed. Subjects were then
challenged with increasing concentrations of Df antigen
(prepared at the appropriate concentration with sterile saline
just prior to administration) as described above. The Df
antigen was administered to the right nasal cavity at a fixed
volume of 150 L via a mucosal atomizer device directed at
the right inferior turbinate. After the 20-minute recording by
ORM at the final Df challenge amount, five measurements
from each nostril were taken with the AcR. The average
value from these five measurements was reported as the
final cross-sectional area (CSA).
Statistical Techniques
The Spearman nonparametric correlation was used to com-
pare change in optical density (OD) and changes in sub-
jective ratings of nasal congestion based on the VAS after
each Df challenge. Mean CSA readings from the AcR be-
fore and after final antigen challenge were compared to
OD before and after the final antigen challenge. The crit-
ical alpha level was set at P  0.05 for all tests, and all P
values quoted are two-tailed unless otherwise indicated.
Results
Less Dust Mite Needed in AR versus Non-AR
Subjects to Incite Positive Response in Nasal
Provocation Testing
The median minimum concentration of Df required to incite
a positive response in AR subjects was 5000 AU/mL. As
expected, a majority of the HCs did not respond to even the
highest amount of Df. Only one HC subject had a positive
ORM response, which was to the highest applied concen-
tration of Df (10,000 AU/mL).
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Mite Antigen
Figure 1 illustrates the relationship between the changes in
OD and VAS with increasing challenging concentrations of
Df and the correlation between ORM and subjective rating
Figure 1 Change in optical density (OD) by optical rhinometry
correlates with change in subjective rating of nasal congestion by
visual analogue scale (VAS). (A) Mean change in OD in healthy
control (HC; white bar) and allergic rhinitis (AR; black bar)
subjects at increasing concentrations of Dermatophagoides farinae
(Df). (B) Mean change in VAS for HC (white bar) and AR (black
bar) subjects at increasing concentrations of Df. (C) Correlation of
change in OD with change in VAS for nasal congestion.of nasal congestion. Figure 1A and B shows that both mean
change in OD and VAS increase with higher amounts of Df
used in the NPT. This trend is clearly evident in the AR
subjects, and to a lesser extent in the HCs. Figure 1C depicts
the correlation between the change in OD as measured by
ORM and change in subjective rating of nasal congestion by
VAS, r  0.63 (P  0.0007).
Optical Rhinometry Correlates with Acoustic
Rhinometry
Figure 2 shows the correlation between change in OD and
change in mCSA1 and mCSA2 on the right nasal cavity,
r  0.60 and 0.64, respectively. The right side repre-
sents the side that was challenged by NPT. The mCSA1
represents the minimum cross-sectional area between 0 and
22 mm from the nasal vestibule, and mCSA2 is the mini-
mum cross-sectional area between 22 and 54 mm. For
comparison, there was a poor correlation between change in
OD and change in mCSA1 and mCSA2 on the left. The r
values were 0.024 and 0.073, respectively.
Discussion
This follow-up study evaluates ORM for assessing nasal
patency during NPT. The first study showed a strong cor-
relation between ORM and subjective ratings of nasal con-
gestion using histamine and oxymetazoline challenges.
In this study, ORM was sensitive enough to detect
changes in nasal patency after Df challenge in AR subjects.
Only one AR subject did not have a change in OD greater
than or equal to 0.2 after challenges with all three Df
concentrations. Rather, the maximum change in OD was
0.17 in this subject. On the other hand, only one HC had a
change in OD greater than 0.2 (OD was 0.35) and char-
acterized as a positive response by ORM. This occurred at
the highest Df concentration tested. These findings support
that ORM is sensitive enough to detect changes in nasal
patency by Df antigen in AR subjects.
The current study also supports the conclusion of the initial
study, since strong correlation between ORM and changes in
subjective ratings of nasal congestion after challenge with Df
(Fig 1) were noted. In addition to this correlation, ORM also
correlates well with acoustic rhinometry (Fig 2).
Acoustic rhinometry is an accepted and validated tech-
nique for assessing nasal patency during NPT. However, its
limitations, including sensitivity to malpositioning and need
to occlude the nasal cavity during measurements, make it a
less than optimal monitoring device. ORM addresses some
of the current limitations of the available monitoring de-
vices and provides some clear advantages, such as contin-
uous monitoring during the entire NPT, ease of use, and
patient comfort. Given the strong correlation between AcR
and ORM, these preliminary studies suggest that ORM may
represent an alternative technique for assessing nasal pa-
tency during NPT with Df antigen.
Some limitations of ORM were encountered. For one,
there was notable variability in the readings during facial
n the s
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subjects with wide nasal bridges were difficult to measure by
ORM. By design of the optical rhinometer, the photo emitter
and detector need to be aligned across the nasal bridge. This
configuration is difficult to sustain in a subject with a flat nasal
bridge. Finally, since the light emitter and detector lie across
the nasal bridge, the measurements are not lateralized. Despite
these few limitations, ORM seems to represent a good alter-
native device for assessing nasal patency.
Based on these pilot results, further studies on ORM are
warranted. Current ongoing studies are assessing ORM for
NPT with other common antigens.
Conclusion
Optical rhinometry can detect changes in nasal congestion
in AR subjects challenged with Df antigen. In addition to
correlating with subjective ratings of nasal congestion,
ORM correlates strongly with acoustic rhinometry. Optical
rhinometry may present an alternative device to acoustic
rhinometry for NPT with Df.
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